-
EP2760469
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2760469
| EP2760469 - RECOMBINANT NANOPARTICLE RSV F VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.03.2017 Database last updated on 24.08.2024 | |
| Former | Examination is in progress Status updated on 15.12.2016 | Most recent event Tooltip | 24.03.2017 | Application deemed to be withdrawn | published on 26.04.2017 [2017/17] | Applicant(s) | For all designated states Novavax, Inc. 9920 Belward Campus Drive Rockville, MD 20850 / US | [2014/32] | Inventor(s) | 01 /
SMITH, Gale c/o NOVAVAX INC. 9920 Belward Campus Drive Rockville, MD 20850 / US | 02 /
WU, Yingyun c/o NOVAVAX INC. 9920 Belward Campus Drive Rockville, MD 20850 / US | 03 /
MASSARE, Michael c/o NOVAVAX INC. 9920 Belward Campus Drive Rockville, MD 20850 / US | 04 /
LIU, Ye c/o NOVAVAX INC. 9920 Belward Campus Drive Rockville, MD 20850 / US | [2014/32] | Representative(s) | Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ / GB | [N/P] |
| Former [2014/32] | Tollervey, Rebecca Marie, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | Application number, filing date | 12835033.7 | 27.09.2012 | WO2012US57546 | Priority number, date | US201161542040P | 30.09.2011 Original published format: US 201161542040 P | US201161542721P | 03.10.2011 Original published format: US 201161542721 P | US201261611834P | 16.03.2012 Original published format: US 201261611834 P | US201261614286P | 22.03.2012 Original published format: US 201261614286 P | [2014/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013049342 | Date: | 04.04.2013 | Language: | EN | [2013/14] | Type: | A1 Application with search report | No.: | EP2760469 | Date: | 06.08.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.04.2013 takes the place of the publication of the European patent application. | [2014/32] | Search report(s) | International search report - published on: | US | 04.04.2013 | (Supplementary) European search report - dispatched on: | EP | 17.02.2015 | Classification | IPC: | A61K39/155 | [2014/32] | CPC: |
A61K39/155 (EP,US);
A61K39/12 (EP,US);
A61P31/12 (EP);
A61P31/14 (EP);
A61P37/04 (EP);
C07K14/005 (EP,US);
C07K14/135 (US);
C12N7/00 (US);
A61K2039/5258 (EP,US);
A61K2039/54 (US);
A61K2039/55505 (EP,US);
A61K2039/55555 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/32] | Title | German: | REKOMBINANTER RSV-F-NANOPARTIKELIMPFSTOFF GEGEN RESPIRATORISCHES SYNZYTIALVIRUS | [2014/32] | English: | RECOMBINANT NANOPARTICLE RSV F VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS | [2014/32] | French: | VACCIN F DE RSV À NANOPARTICULE RECOMBINANTE POUR LE VIRUS RESPIRATOIRESYNCYTIAL | [2014/32] | Entry into regional phase | 28.03.2014 | National basic fee paid | 28.03.2014 | Search fee paid | 28.03.2014 | Designation fee(s) paid | 28.03.2014 | Examination fee paid | Examination procedure | 28.03.2014 | Examination requested [2014/32] | 04.01.2016 | Amendment by applicant (claims and/or description) | 09.05.2016 | Despatch of a communication from the examining division (Time limit: M06) | 22.11.2016 | Application deemed to be withdrawn, date of legal effect [2017/17] | 16.12.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/17] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 09.05.2016 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 04.01.2016 | Request for further processing filed | 04.01.2016 | Full payment received (date of receipt of payment) Request granted | 25.01.2016 | Decision despatched | Fees paid | Renewal fee | 29.09.2014 | Renewal fee patent year 03 | 28.09.2015 | Renewal fee patent year 04 | 27.09.2016 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2010077717 (NOVAVAX INC [US], et al) [X] 1-15 * the whole document, in particular examples 1-11, claims 1-74 and paragraphs 61, 77, 78, 97, 135, 154 *; | [XP] - Gregory Glenn, "Recombinant, Insect Cell-Derived RSV Nanoparticle Vaccine", MVADS Copenhagen, (20120704), URL: https://www.novavax.com/download/file/RSV nanoparticle Vaccine-MVADsJuly4(2).pdf, (20150206), XP055167854 [XP] 1-15 * the whole document * | International search | [A]US2005142148 (FOUCHIER RONALDUS A M [NL], et al); | [X]US2010239617 (PUSHKO PETER [US], et al); | [A]US2010291147 (BAUDOUX GUY JEAN MARIE FERNAND PIERRE [BE], et al); | [A] - WHITEHEAD ET AL., "Recombinant Respiratory Syncytial Virus (RSV) Bearing a Set of Mutations from Cold-Passaged RSV Is Attenuated in Chimpanzees", JOURNAL OF VIROLOGY, (19980501), vol. 72, no. 5, pages 4467 - 4471, XP055147381 |